The Ledger / Tse Ping & family
Tse Ping & family
◼ Origin
Founded Sino Biopharmaceutical Limited (HKEX: 1177) in Hong Kong, building it into one of China's largest pharmaceutical companies with drugs targeting hepatitis, cardiovascular disease, and oncology. Connected to Thailand's Charoen Pokphand (CP Group) through family ties — he serves as CP Group vice chairman — though Sino Biopharmaceutical was developed independently of the family's agribusiness.
◼ Self-Made Verdict — PARTIAL
Founded Sino Biopharmaceutical independently, but benefited substantially from CP Group family networks and capital access that would not have been available without those connections.
◼ Documented marks
01
Founder and Chairman of Sino Biopharmaceutical Limited (HKEX: 1177), one of China's largest pharmaceutical companies
02
Vice Chairman of Charoen Pokphand (CP Group), Thailand's largest conglomerate, through family connections
03
In 2019, transferred approximately $3.8 billion worth of Sino Biopharmaceutical shares to his son Eric Tse
04
Chinese state broadcaster CCTV accused a Sino Biopharmaceutical majority-owned subsidiary of systematically bribing doctors with overseas travel in 2013; shares dropped 25% before trading was halted
05
Portfolio includes hepatitis, cardiovascular, oncology, and metabolic disease drugs primarily sold in China
No inheritance, or primary accounts documented for this billionaire yet.
◼ List of charges
Total sentence
0–0 years
That is
0.0–0.0 life sentences
(using 78 years as one life)
At $1 million per day
Tse Ping & family's fortune would last 13 years
0.2 lifetimes of luxury — before running out.
These are moral charges, not legal ones. The actual legal system has not — and will not — bring them.
More ledger entries